207 related articles for article (PubMed ID: 10816529)
1. Role of EspB in experimental human enteropathogenic Escherichia coli infection.
Tacket CO; Sztein MB; Losonsky G; Abe A; Finlay BB; McNamara BP; Fantry GT; James SP; Nataro JP; Levine MM; Donnenberg MS
Infect Immun; 2000 Jun; 68(6):3689-95. PubMed ID: 10816529
[TBL] [Abstract][Full Text] [Related]
2. Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection.
Donnenberg MS; Tacket CO; James SP; Losonsky G; Nataro JP; Wasserman SS; Kaper JB; Levine MM
J Clin Invest; 1993 Sep; 92(3):1412-7. PubMed ID: 8376594
[TBL] [Abstract][Full Text] [Related]
3. Antibody response of children with enteropathogenic Escherichia coli infection to the bundle-forming pilus and locus of enterocyte effacement-encoded virulence determinants.
Martinez MB; Taddei CR; Ruiz-Tagle A; Trabulsi LR; Girón JA
J Infect Dis; 1999 Jan; 179(1):269-74. PubMed ID: 9841853
[TBL] [Abstract][Full Text] [Related]
4. Genetically engineered enteropathogenic Escherichia coli strain elicits a specific immune response and protects against a virulent challenge.
Boullier S; Nougayrède JP; Marchès O; Tasca C; Boury M; Oswald E; De Rycke J; Milon A
Microbes Infect; 2003 Aug; 5(10):857-67. PubMed ID: 12919854
[TBL] [Abstract][Full Text] [Related]
5. Characterization of two virulence proteins secreted by rabbit enteropathogenic Escherichia coli, EspA and EspB, whose maximal expression is sensitive to host body temperature.
Abe A; Kenny B; Stein M; Finlay BB
Infect Immun; 1997 Sep; 65(9):3547-55. PubMed ID: 9284118
[TBL] [Abstract][Full Text] [Related]
6. Protein translocation into host epithelial cells by infecting enteropathogenic Escherichia coli.
Wolff C; Nisan I; Hanski E; Frankel G; Rosenshine I
Mol Microbiol; 1998 Apr; 28(1):143-55. PubMed ID: 9593303
[TBL] [Abstract][Full Text] [Related]
7. Two enteropathogenic Escherichia coli type III secreted proteins, EspA and EspB, are virulence factors.
Abe A; Heczko U; Hegele RG; Brett Finlay B
J Exp Med; 1998 Nov; 188(10):1907-16. PubMed ID: 9815268
[TBL] [Abstract][Full Text] [Related]
8. The EspB protein of enteropathogenic Escherichia coli is targeted to the cytoplasm of infected HeLa cells.
Taylor KA; O'Connell CB; Luther PW; Donnenberg MS
Infect Immun; 1998 Nov; 66(11):5501-7. PubMed ID: 9784563
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Adhesion of Enteropathogenic Escherichia coli to HEp-2 Cells by Binding of a Novel Peptide to EspB Protein.
Li D; Chen Z; Cheng H; Zheng JX; Pan WG; Yang WZ; Yu ZJ; Deng QW
Curr Microbiol; 2016 Sep; 73(3):361-365. PubMed ID: 27246497
[TBL] [Abstract][Full Text] [Related]
10. The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor.
Levine MM; Nataro JP; Karch H; Baldini MM; Kaper JB; Black RE; Clements ML; O'Brien AD
J Infect Dis; 1985 Sep; 152(3):550-9. PubMed ID: 2863318
[TBL] [Abstract][Full Text] [Related]
11. Intranasal co-administration of recombinant active fragment of Zonula occludens toxin and truncated recombinant EspB triggers potent systemic, mucosal immune responses and reduces span of E. coli O157:H7 fecal shedding in BALB/c mice.
Shekar A; Ramlal S; Jeyabalaji JK; Sripathy MH
Med Microbiol Immunol; 2019 Feb; 208(1):89-100. PubMed ID: 30209565
[TBL] [Abstract][Full Text] [Related]
12. Association between intimin (eae) and EspB gene subtypes in attaching and effacing Escherichia coli strains isolated from diarrhoeic lambs and goat kids.
Cid D; Ruiz-Santa-Quiteria JA; Marı N I; Sanz R; Orden JA; Amils R; de la Fuente R
Microbiology (Reading); 2001 Aug; 147(Pt 8):2341-2353. PubMed ID: 11496011
[TBL] [Abstract][Full Text] [Related]
13. Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge.
Donnenberg MS; Tacket CO; Losonsky G; Frankel G; Nataro JP; Dougan G; Levine MM
Infect Immun; 1998 Jan; 66(1):52-8. PubMed ID: 9423838
[TBL] [Abstract][Full Text] [Related]
14. Attaching and effacing enteropathogenic Escherichia coli O18ab invades epithelial cells and causes persistent diarrhea.
Scaletsky IC; Pedroso MZ; Fagundes-Neto U
Infect Immun; 1996 Nov; 64(11):4876-81. PubMed ID: 8890257
[TBL] [Abstract][Full Text] [Related]
15. The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function.
Iizumi Y; Sagara H; Kabe Y; Azuma M; Kume K; Ogawa M; Nagai T; Gillespie PG; Sasakawa C; Handa H
Cell Host Microbe; 2007 Dec; 2(6):383-92. PubMed ID: 18078690
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the function of enteropathogenic Escherichia coli EspB by random mutagenesis.
Luo W; Donnenberg MS
Infect Immun; 2006 Feb; 74(2):810-20. PubMed ID: 16428723
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous inactivation of espB and tir abrogates the strong, but non-protective, inflammatory response induced by EPEC.
Lefoll C; Caubet C; Tasca C; Milon A; Boullier S
Vet Immunol Immunopathol; 2010 Nov; 138(1-2):34-44. PubMed ID: 20633933
[TBL] [Abstract][Full Text] [Related]
18. Esp-independent functional integration of the translocated intimin receptor (Tir) of enteropathogenic Escherichia coli (EPEC) into host cell membranes.
Michgehl S; Heusipp G; Greune L; Rüter C; Schmidt MA
Cell Microbiol; 2006 Apr; 8(4):625-33. PubMed ID: 16548888
[TBL] [Abstract][Full Text] [Related]
19. Human response to Escherichia coli O157:H7 infection: antibodies to secreted virulence factors.
Li Y; Frey E; Mackenzie AM; Finlay BB
Infect Immun; 2000 Sep; 68(9):5090-5. PubMed ID: 10948130
[TBL] [Abstract][Full Text] [Related]
20. Cytopathic effects of outer-membrane preparations of enteropathogenic Escherichia coli and co-expression of maltoporin with secretory virulence factor, EspB.
Kumar SS; Sankaran K; Haigh R; Williams PH; Balakrishnan A
J Med Microbiol; 2001 Jul; 50(7):602-612. PubMed ID: 11444770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
